# Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES

> **NCT03236415** · NA · WITHDRAWN · sponsor: **Ottawa Heart Institute Research Corporation**

## Conditions studied

- Coronary Artery Disease
- Diabetes Mellitus

## Interventions

- **DEVICE:** Xience Drug Eluting Stent
- **DEVICE:** ABSORB Bioresorbable Vascular Scaffold

## Key facts

- **NCT ID:** NCT03236415
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-08
- **Primary completion:** 2019-07
- **Final completion:** 2019-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Global sales of the Absorb BVS halted effective September 14, 2017.
- **Last updated:** 2017-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03236415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03236415, "Comparative Response to Vascular Injury in Patients With Diabetes Mellitus: An OCT Study of BVS Versus Xience DES". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03236415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*